Hui Yi

616 citations
14 papers · 357 indexed · h-index 9
Topics
Mesenchymal stem cell research (3 papers)COVID-19 Clinical Research Studies (3 papers)SARS-CoV-2 and COVID-19 Research (2 papers)
Partner nations
ChinaHong Kong

In The Last Decade

Hui Yi

12 papers receiving 352 citations

Peers

Hui Yi
Comparison fields: 5 of 68
  • Infectious Diseases 113
  • Molecular Biology 81
  • Neurology 50
  • Epidemiology 48
  • Immunology 45
Replace Meng Zhao with:
Meng Zhao China
Alicia N. Rizzo United States
Hedieh Moradi Tabriz Iran
Guoyan Lu China
Ewelina Józefczuk Poland
Matthew J. McConnell United States
Lin Cai China
Yunye Ning China
Mee Jeong Lee South Korea
Sara Bruzzaniti Italy
Hui Yi relative to Meng Zhao China Meng Zhao's profile →
Citations per field
00.5×1.5×2.3×
Meng Zhao · 1×
Citations per year

Countries citing papers authored by Hui Yi

Since Specialization
Citations

This map shows the geographic impact of Hui Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Yi more than expected).

Fields of papers citing papers by Hui Yi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Yi. The network helps show where Hui Yi may publish in the future.

Co-authorship network of co-authors of Hui Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Yi. A scholar is included among the top collaborators of Hui Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Yi. Hui Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 0
2 0
3 4
4 13
5 37
6 15
7 8
8 102
9 48
10 44
11 42
12 36
13
[Expression and function of zinc ribbon gene ZNRD1 in drug-resistant gastric cancer cells].
3
14
[Protective effect of selective cyclooxygenase-2 inhibitor on alcohol-induced liver injury in rats].
5

About Hui Yi

Hui Yi is a scholar working on Biological Psychiatry, Genetics and Complementary and alternative medicine, having authored 14 papers that have together received 357 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (3 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Infectious Diseases (113 citations), Genetics (39 citations) and Neurology (50 citations). Hui Yi has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Juan Xie, Jing Ma, Jingwen Si, Junchang Li, Zongren Wang, Huan Wang, Wen Wang, Qingui Chen, Wanmei He and Mian Zeng. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and American Journal of Physiology-Lung Cellular and Molecular Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026